ArticleAnnals of surgical oncology2026
Does Splenic Hilar Lymph Node Harvesting Impact Outcomes After Total Gastrectomy for Cancer? A Multi-Institutional Retrospective Study With Propensity Score-Matching.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBenefit of splenic hilar lymph nodes (group n°10 or LN10 according to the Japanese gastric cancer association classification) harvesting during total gastrectomy for cancer is still debated, especially because of both uncertain positive impact on oncologic outcomes and reported increased intra- and postoperative morbidity. Our aim was to investigate the real value of LN10 harvesting in total gastrectomy.
methodsData were analyzed from the ADENOKGAST multi-institutional retrospective database, conducted between 2007 and 2017. A propensity score analysis was performed using the inverse probability of treatment weighting method. Preoperative factors for recurrence were analyzed in univariate and multivariate models to create a risk score (proportional to Odds Ratios), allowing two groups of patients to be distinguished: low and high risk for recurrence. Survivals were studied using Kaplan-Meier methods and Cox models.
results514 patients were analyzed. Patients who underwent LN10 harvesting (LN10+) (n=84) or not (LN10-) (n=430) were compared. 30-day severe postoperative morbidity (p=0.7) and 90-day postoperative mortality (p=0.3) were similar. Mean length of hospital stay was slightly increase in LN10+ patients (19.7 vs 20.6 days; p=0.03). Recurrence rates (36% vs 40%; p=0.7) and recurrence location (OR=1.2; p=0.85) were similar, as well as both overall survival (OS) (HR=0.84; IC95=[0.44;1.58]; p=0.6) and recurrence-free survival (RFS) (HR=1.1; IC95=[0.64;1.91]; p=0.7). Among patients with high risk for recurrence, there was no benefit neither on OS nor RFS of LN10 harvesting.
conclusionsLN10 harvesting did not improve neither OS nor RFS following total gastrectomy for gastric cancer, even in patients with high risk for recurrence.
Indexed as
Identifiers
41261269What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.